bpc-157 research human trials safety studies review Orthopedic Use of BPC-157 The Hidden Risks of BPC‑157:
Description
Yet, in the three-plus decades since BPC-157 was discovered, no controlled human trial of the peptide has ever been published
These are often referred to as MICC injections: Methionine Inositol Choline Cyanocobalamin , a form of B12 Other formulations of lipotropic injections with B12 exist, but MICC is among the most common
Potential Benefits: Targeted Fat Loss: Primarily reduces visceral fat, which is linked to a higher risk of diabetes, heart disease, and metabolic syndrome
The alteration in composition and function of gut microbiome in patients with type 2 diabetes
